Summit Therapeutics, Inc. (SMMT)
13.04
-1.26
(-8.78%)
USD |
NASDAQ |
Jun 10, 16:00
13.06
+0.02
(+0.15%)
After-Hours: 17:35
Summit Therapeutics Total Assets (Quarterly) : 647.86M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 647.86M |
| December 31, 2025 | 751.18M |
| September 30, 2025 | 261.73M |
| June 30, 2025 | 324.04M |
| March 31, 2025 | 383.82M |
| December 31, 2024 | 435.56M |
| September 30, 2024 | 502.85M |
| June 30, 2024 | 341.86M |
| March 31, 2024 | 176.78M |
| December 31, 2023 | 202.95M |
| September 30, 2023 | 218.48M |
| June 30, 2023 | 237.37M |
| March 31, 2023 | 254.90M |
| December 31, 2022 | 664.17M |
| September 30, 2022 | 155.33M |
| June 30, 2022 | 95.72M |
| March 31, 2022 | 116.47M |
| December 31, 2021 | 113.37M |
| September 30, 2021 | 128.67M |
| June 30, 2021 | 145.52M |
| March 31, 2021 | 140.79M |
| December 31, 2020 | 102.50M |
| September 30, 2020 | 56.86M |
| Date | Value |
|---|---|
| June 30, 2020 | |
| March 31, 2020 | 89.02M |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | 78.62M |
| October 31, 2018 | 57.28M |
| July 31, 2018 | 61.36M |
| April 30, 2018 | 83.52M |
| January 31, 2018 | 76.74M |
| October 31, 2017 | 64.64M |
| July 31, 2017 | 54.26M |
| April 30, 2017 | 39.98M |
| January 31, 2017 | 47.29M |
| October 31, 2016 | 52.44M |
| July 31, 2016 | 19.42M |
| April 30, 2016 | 29.59M |
| January 31, 2016 | 35.57M |
| October 31, 2015 | 45.47M |
| July 31, 2015 | 52.44M |
| April 30, 2015 | 57.31M |
| January 31, 2015 | 29.13M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.254B |
| Denali Therapeutics, Inc. | 1.266B |
| NovelStem International Corp. | 0.1009M |
| Brainstorm Cell Therapeutics, Inc. | 0.755M |
| Kezar Life Sciences, Inc. | 68.00M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 101.92M |
| Shareholders Equity (Quarterly) | 545.93M |
| Debt to Equity Ratio | 0.0367 |
| Current Ratio | 7.405 |
| Net Debt Paydown Yield | -0.02% |